ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 46 filers reported holding ENOCHIAN BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $857,042 | +501.5% | 191,732 | -23.8% | 0.00% | – |
| Q2 2023 | $142,487 | +418979.4% | 251,478 | +583.8% | 0.00% | – |
| Q1 2023 | $34 | -37.0% | 36,774 | -30.4% | 0.00% | – |
| Q4 2022 | $54 | -99.9% | 52,814 | +59.2% | 0.00% | – |
| Q3 2022 | $60,000 | -58.0% | 33,183 | -55.3% | 0.00% | – |
| Q2 2022 | $143,000 | -90.7% | 74,184 | -60.3% | 0.00% | -100.0% |
| Q1 2022 | $1,541,000 | +227.9% | 186,812 | +189.6% | 0.00% | – |
| Q4 2021 | $470,000 | -19.0% | 64,502 | -44.7% | 0.00% | – |
| Q2 2021 | $580,000 | +349.6% | 116,666 | +222.7% | 0.00% | – |
| Q3 2020 | $129,000 | +290.9% | 36,155 | +230.4% | 0.00% | – |
| Q1 2020 | $33,000 | -78.1% | 10,943 | -60.3% | 0.00% | – |
| Q3 2019 | $151,000 | -57.5% | 27,585 | -65.1% | 0.00% | -100.0% |
| Q2 2019 | $355,000 | -33.1% | 78,934 | +3.1% | 0.00% | 0.0% |
| Q1 2019 | $531,000 | – | 76,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |